Peri-operative Sintilimab in Combination With SOX in Locally Advanced Gastric Cancer

NCT04982939 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

210

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer
Perioperative
Sintilimab

Interventions

DRUG: Sintilimab
DRUG: S-1
DRUG: Oxaliplatin

Sponsor

Tianjin Medical University Cancer Institute and Hospital